Background
Clinical Question
Synthesizing Evidence
Proposed Changes
Implications & Recommendations
100

This clinical problem occurs when neonates develop bloodstream infections related to central lines.

What is CLABSI in neonates?

100

This type of dressing has strong evidence showing it reduces CLABSI in NICU patients.

What is a Chlorhexidine (CHG) dressing?

100

This organ should be assessed when a nurse applies a chlorhexidine dressing.

What is the skin?

100

True or False: Our AIMS statement includes reducing CLABSI rates in the NICU within six months.

What is true?

100

CHG dressings should be introduced using this type of process.

What is a structured and evidence-based approach?

200

True or False: CHG dressings are widely used and common in clinical settings.

What is false?

200

What are central venous catheter treatments?

Fluid therapy, blood transfusions, and nutrition

200

Using chlorhexidine dressings alongside this technique results in lower CLABSI rates.

What is sterile technique?

200

This quality improvement model guided our implementation plan for reducing CLABSI in the NICU.

What is the PDSA model?

200

Randomized controlled trials show that CHG dressings reduce microbial growth at these sites.

What are catheter insertion sites?

300

These two major complications of CLABSI lead to worse outcomes for infants.

What are longer hospital stays and higher mortality rates?

300

In one study, implementing a CHG maintenance bundle resulted in this percentage reduction in infection rates.

What is 95%?

300

To achieve the best outcomes, CHG dressings should be paired with this individualized approach to patient care.

What is personalized care?

300

Method(s) we plan to use to support the implementation of CHG dressings.

What is staff training / data collection / collaboration / meetings / a trial run?

300

Because these patients have fragile skin, CHG dressings must be applied gently and monitored closely.

Who are preterm or very-low-birth-weight neonates?